Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
UTC Therapeutics Inc.
Jiangsu HengRui Medicine Co., Ltd.
NGM Biopharmaceuticals, Inc
Dublin City University
University Health Network, Toronto
ImmVira Pharma Co. Ltd
University Hospital, Ghent
Centre Hospitalier Universitaire Vaudois
University of British Columbia
Kaiser Permanente
Zhejiang University
Universitätsklinikum Hamburg-Eppendorf
Peking Union Medical College Hospital
Peking Union Medical College Hospital
University Health Network, Toronto
University Health Network, Toronto
Guangxi Medical University
University Medical Center Groningen
Precision Robotics (Hong Kong) Limited
Royal Surrey County Hospital NHS Foundation Trust
National Cancer Institute, Naples
Advenchen Laboratories, LLC
Multitude Therapeutics Inc.
Loyola University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Immix Biopharma, Inc.
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd
Peter MacCallum Cancer Centre, Australia
CureLab Oncology
Precision Robotics (Hong Kong) Limited
Liaoning Cancer Hospital & Institute
Second Affiliated Hospital of Guangzhou Medical University
Kineta Inc.
Seoul National University Hospital
Shanghai Yunying Medical Technology
Ruijin Hospital
Hunan Cancer Hospital
Fudan University
The First Affiliated Hospital of Xiamen University
Shanghai Yunying Medical Technology
Hangzhou Cheetah Cell Therapeutics Co., Ltd
National Cancer Institute, Naples
National Cancer Institute, Naples
National Cancer Institute, Naples
National Cancer Institute, Naples
National Cancer Institute, Naples
National Cancer Institute, Naples
National Cancer Institute, Naples
Assiut University